# SURPASS Impella 5.5 Study

> **NCT05100836** · — · COMPLETED · sponsor: **Abiomed Inc.** · enrollment: 1017 (actual)

## Conditions studied

- Cardiogenic Shock
- Acute Decompensated Heart Failure

## Interventions

- **DEVICE:** Impella 5.5

## Key facts

- **NCT ID:** NCT05100836
- **Lead sponsor:** Abiomed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-21
- **Primary completion:** 2025-05-14
- **Final completion:** 2025-05-14
- **Target enrollment:** 1017 (ACTUAL)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100836, "SURPASS Impella 5.5 Study". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05100836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*